Back to Search Start Over

Dramatic Response to Carboplatin Plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis.

Authors :
Oda N
Tabata M
Uno M
Umeda Y
Kato H
Kubo T
Senoo S
Yagi T
Fujiwara T
Maeda Y
Kiura K
Source :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Sep 15; Vol. 60 (18), pp. 2967-2971. Date of Electronic Publication: 2021 Apr 05.
Publication Year :
2021

Abstract

Mucinous cystic neoplasm (MCN) of the pancreas is a rare cystic tumor occurring in the pancreatic body and tail in young to middle-aged women that is pathologically characterized by an ovarian-like stroma. Chemotherapy for recurrent/advanced pancreatic MCN has been based on chemotherapy regimens for pancreatic ductal adenocarcinoma, but the prognosis is poor. We herein report a 37-year-old woman with pancreatic mucinous cystadenocarcinoma with liver metastasis that responded dramatically to carboplatin plus paclitaxel therapy (CBDCA+PTX). CBDCA+PTX may be a treatment option for recurrent/advanced pancreatic MCN with an ovarian-like stroma.

Details

Language :
English
ISSN :
1349-7235
Volume :
60
Issue :
18
Database :
MEDLINE
Journal :
Internal medicine (Tokyo, Japan)
Publication Type :
Academic Journal
Accession number :
33814494
Full Text :
https://doi.org/10.2169/internalmedicine.6730-20